New Options in GLP-1 RA Therapy

These free CME/CE activities are designed for diabetes-treating clinicians, including endocrinologists, diabetologists, primary care physicians, physician assistants, nurse practitioners, nurses, certified diabetes educators, and other healthcare providers who are involved in the management of patients with T2DM.

Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are one of the most versatile classes of agents for treating type 2 diabetes mellitus (T2DM). Current guidelines strongly recommend GLP-1 RAs, noting that these agents offer multiple therapeutic benefits for patients, including high glycemic efficacy, a low risk of hypoglycemia, and the potential for weight loss. Some have even been shown to have cardiovascular benefits, a long-sought goal of T2DM treatment. New and emerging GLP-1 RAs provide additional options to further individualize regimens for the treatment of T2DM. Offered in a variety of formats, these engaging activities will help clinicians recognize the unique characteristics of GLP-1 RAs when making patient-centered treatment decisions.

Click to proceed to any of the 2 activities above!